Authors
Latest:
To Mask or Not To Mask? Why Is This Even a Question?Politics have gotten in the way of mask-wearing, and they should not.
Latest:
Perspectives on Global Women’s Mental HealthThis diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
Latest:
Comparing COVID Doctors and 9/11 First RespondersDecades after September 11, 2001, many first responders still live with PTSD. Will the same be true of physicians who saw the worst of the pandemic?
Latest:
Therapists in the Patient’s ChairHow can we combat compassion fatigue by practicing what we preach?
Latest:
Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype CycleNew approaches to ensure that the brain health technology sector continues to flourish for decades.
Latest:
STAR*D: It’s Time to Atone and Retract“Our patients, our field, and our integrity demand a better explanation of what happened in STAR*D than what has thus been provided.”
Latest:
Exploring PTSD and TBI in Sports and MilitaryHow are these conditions connected, and what are the unique risks for athletes and military personnel?
Latest:
Love, Alzheimer Disease, and Medical Aid in DyingApproximately 6.5 million Americans are living with Alzheimer disease today, and that number is projected to rise to about 13 million by 2050.
Latest:
Unraveling Minds: The Impact of Global Climate Change on Mental HealthClimate change is a global public health crisis.
Latest:
Treatment-Resistant Geriatric Depression: Augmenting or Switching an AntidepressantRecent research investigated the benefits and risks of augmentation compared with switching strategies for TRD in older adults.
Latest:
A Brainier Approach to ESG InvestingDevoting funds to better benefit brain health could improve society as a whole.
Latest:
The Impact of Cannabis Use on Medication Nonadherence in PsychiatryCannabis use disorder and nonadherence: How can we best educate patients?
Latest:
How to Navigate and Treat ‘New Year Depression’ in Your PatientsThere may not be a diagnosis for ‘New Year Depression,’ about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Latest:
The Unutterable RagePoetry approaches the visceral experience of intense emotion better than prose or medical reports.
Latest:
Case Report: Addressing Stigma and Shame in the Treatment of OCDAddressing shame in the treatment of OCD is a crucial component of the therapeutic process. Here’s what you need to know.
Latest:
Treating Cognitive Impairment in Patients with SchizophreniaA recent drug trial yields encouraging results.
Latest:
A New CME: Continuing Moral EducationEvery phase of the COVID-19 pandemic brings new ethical challenges.
Latest:
10 Measures and Outcomes to Assess Progress in Eradicating RacismSuggestions to assess outcomes and measure success levels in combatting racism.
Latest:
STAR*D’s Cumulative Remission Rate and Why It Still MattersContesters of STAR*D discuss the impact and relevance of the study's remission rates.
Latest:
The Confluence of Human Trafficking, Drug Trafficking, Militias, and Substance UseExplore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.
Latest:
Abortion and the Psychiatrist: Practicing in Post-Dobbs America"The psychiatrist may be obligated to protect the fetus or warn authorities of the patient’s intent."
Latest:
Including Racism in a Trauma History: A Clinician’s ReflectionsPsychiatry has changed, and we now have an acute awareness of the cost of sexual trauma to patients. When it comes to race, however, we still have a lot to learn.
Latest:
Sex, Drugs, and Psychosis: Reviewing Psychiatric Medications’ Taboo Side EffectThe sexual side effects of psychiatric medications are troubling enough that some patients consider treatment cessation. The authors review 5 strategies for managing sexual dysfunction.
Latest:
The Cardiovascular Consequences of Drug UseSome commonly used drugs and narcotics have serious cardiovascular effects.
Latest:
Mental Health Stigma for Providers: A Hidden Challenge Among UsStigma poses a serious risk to quality of care and accessibility.
Latest:
How Do We Grieve?A resident reflects on the clinician experience of loss and grief, and how these emotions can help decrease the distance between clinicians and patients.
Latest:
Phase 3 Trials Examine Gantenerumab for Early Alzheimer DiseaseTwo phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.
